Ushigome F, Takanaga H, Matsuo H, Yanai S, Tsukimori K, Nakano H, Uchiumi T, Nakamura T, Kuwano M, Ohtani H, Sawada Y
Department of Medico-Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Eur J Pharmacol. 2000 Nov 10;408(1):1-10. doi: 10.1016/s0014-2999(00)00743-3.
To elucidate the role of P-glycoprotein in human placenta, we examined its expression in placenta, and the transcellular transport and uptake of P-glycoprotein substrates in cultured human placental choriocarcinoma epithelial cells (BeWo cells). The uptake of [(3)H]vinblastine and [(3)H]vincristine into BeWo cells was increased in the presence of a metabolic inhibitor, sodium azide. The basolateral-to-apical transcellular transport of [(3)H]vinblastine, [(3)H]vincristine and [(3)H]digoxin was greater than the apical-to-basolateral transcellular transport. In the presence of cyclosporin A, the basolateral-to-apical transcellular transport of [(3)H]vinblastine, [(3)H]vincristine and [(3)H]digoxin was significantly increased, and the apical-to-basolateral transcellular transport was decreased. The uptake of [(3)H]vinblastine, [(3)H]vincristine and [(3)H]digoxin into BeWo cells was significantly enhanced in the presence of several inhibitors, such as verapamil or mouse monoclonal antibody anti-P-glycoprotein MX-MDR (MRK16) as well as cyclosporin A. Although progesterone significantly enhanced the uptake of [(3)H]vinblastine, [(3)H]vincristine and [(3)H]digoxin into BeWo cells, the uptake of [(3)H]progesterone was not affected by these inhibitors. Immunoblot analysis revealed that P-glycoprotein with a molecular weight of 172 kDa was expressed in BeWo cells and isolated trophoblast cells. Furthermore, P-glycoprotein was detected in human placental brush-border membrane vesicles, but not in human placental basolateral membrane vesicles. In conclusion, these data suggest that P-glycoprotein is expressed on the brush-border membrane (maternal side) of human placental trophoblast cells. P-Glycoprotein is considered to regulate the transfer of several substances including vinblastine, vincristine and digoxin from mother to fetus, and to protect the fetus from toxic substances.
为阐明P-糖蛋白在人胎盘中的作用,我们检测了其在胎盘中的表达,以及在培养的人胎盘绒毛膜癌上皮细胞(BeWo细胞)中P-糖蛋白底物的跨细胞转运和摄取情况。在代谢抑制剂叠氮化钠存在的情况下,[(3)H]长春碱和[(3)H]长春新碱进入BeWo细胞的摄取量增加。[(3)H]长春碱、[(3)H]长春新碱和[(3)H]地高辛从基底外侧到顶端的跨细胞转运大于从顶端到基底外侧的跨细胞转运。在环孢素A存在的情况下,[(3)H]长春碱、[(3)H]长春新碱和[(3)H]地高辛从基底外侧到顶端的跨细胞转运显著增加,而从顶端到基底外侧的跨细胞转运减少。在几种抑制剂(如维拉帕米或抗P-糖蛋白小鼠单克隆抗体MX-MDR(MRK16)以及环孢素A)存在的情况下,[(3)H]长春碱、[(3)H]长春新碱和[(3)H]地高辛进入BeWo细胞的摄取量显著增强。虽然孕酮显著增强了[(3)H]长春碱、[(3)H]长春新碱和[(3)H]地高辛进入BeWo细胞的摄取量,但[(3)H]孕酮的摄取不受这些抑制剂的影响。免疫印迹分析显示,分子量为172 kDa的P-糖蛋白在BeWo细胞和分离的滋养层细胞中表达。此外,在人胎盘刷状缘膜囊泡中检测到P-糖蛋白,但在人胎盘基底外侧膜囊泡中未检测到。总之,这些数据表明P-糖蛋白在人胎盘滋养层细胞的刷状缘膜(母体侧)上表达。P-糖蛋白被认为可调节包括长春碱、长春新碱和地高辛在内的几种物质从母体到胎儿的转运,并保护胎儿免受有毒物质的侵害。